Insulin glargine and lixisenatide and NovoSeven RT
Determining the interaction of Insulin glargine and lixisenatide and NovoSeven RT and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: coagulation factor viia
Brand name: NovoSeven RT with MixPro, Novoseven, NovoSeven RT
Synonyms: NovoSeven RT with MixPro (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-NovoSeven RT with MixPro injection
- Insulin glargine and lixisenatide-Novothyrox
- Insulin glargine and lixisenatide-Noxafil
- Insulin glargine and lixisenatide-Noxafil (Posaconazole Delayed-Release Tablets)
- Insulin glargine and lixisenatide-Noxafil (Posaconazole Injection)
- Insulin glargine and lixisenatide-Noxafil (Posaconazole Oral Suspension)
- NovoSeven RT-Insulin glargine and lixisenatide Subcutaneous
- NovoSeven RT-Insulin glargine, recombinant Subcutaneous
- NovoSeven RT-Insulin glulisine
- NovoSeven RT-Insulin Glulisine (Cartridges and Pens)
- NovoSeven RT-Insulin Glulisine (Vials)
- NovoSeven RT-Insulin glulisine Subcutaneous